Table 1 Four different studies showing that between 40% to 70% of previously untreated NPC specimens have loss of p16 expression.
From: Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma
Investigators | Number of NPC specimens examined | Percent of NPC with loss of p16 staining |
|---|---|---|
Hwang et al [13] | 65 | 65% |
Makitie et al [16] | 84 | 70% |
Huang et al [15] | 74 | 42% |
Baba et al [14] | 20 | 40% |
Lin et al [this study] | 27 | 96% |